Amgen's experimental jab causes 20 per cent weight loss in early results
Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...
Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
Daily5h
Semaglutide associated with Nonarteritic Anterior Ischemic Optic Neuropathy: JAMA
Nonarteritic anterior ischemic optic neuropathy (NAION) is the second most common form of optic neuropathy and a significant ...
The Economist5h
Wegovy hits the People’s Republic, at last
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
think12h
The winners and losers of Biden’s plans to expand coverage of weight-loss drugs
The winners and losers of Biden’s plans to expand coverage of weight-loss drugs US President Joe Biden wants to expand the ...
Scandasia.com16h
Novo Nordisk expands footprint in China with recruitment shift
Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...
Suffolk County imposes stricter rules for popular weight loss drug coverage
There has been a lot of conversation lately about if new weight loss drugs like Wegovy and Mounjaro should be covered by ...
Zacks.com on MSN23h
AMGN Stock Down Despite Strong Data From Obesity Drug Study
Key Takeaways A new Amgen weight reduction drug, MariTide, has bred successful results after a 52-week study. Still, AMGN ...